Revvity rises as co expects to exceed 2025 profit forecast

Revvity

12/01/2026 22:31

** Shares of medical equipment maker Revvity RVTY.N rise 6% to $110.40 in extended trading

** Expects 2025 adjusted EPS to exceed its forecast range of $4.90 to $5 given in October

** Sees preliminary Q4 revenue of $772 million vs estimates of $760.3 million - data compiled by LSEG

** RVTY will report Q4 and full-year results on February 2

**  Stock was down 13% in 2025

 (Reporting by Koyena Das in Bengaluru)

 ((koyena.das@thomsonreuters.com))